Clinical trial Recruiting at 1 site Observational Ages 20 to 80

Femtosecond laser arcuate keratotomy to reduce corneal astigmatism during cataract surgery

Official title: Effectiveness, Stability and Influence Factors of Femtosecond Laser Assisted Cataract Surgery

Run by Eye & ENT Hospital of Fudan University · NCT07081919 · Data updated 2026-11-12

This study will try using a computer-guided femtosecond laser cut (FSAK) during cataract surgery to reduce mild-to-moderate corneal astigmatism in adults aged 20–80.

More Cataract trials

Quick facts

Study typeObservational
Ages20 Years to 80 Years
SexAll
Enrollment105 (estimated)
SponsorEye & ENT Hospital of Fudan University
Academic / other
Locations1 site (Shanghai, Shanghai Municipality)
StatusRecruiting
StartedApril 22, 2025
Main results expectedApril 22, 2030
Study endsApril 22, 2031
Registry record updatedJuly 23, 2025
Trial IDNCT07081919 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 20–80 with age-related cataract, regular corneal astigmatism between 0.75 and 2.0 diopters, scheduled for femtosecond laser-assisted cataract surgery, with adequate corneal thickness and endothelial cell count and no prior corneal refractive or intraocular surgery.

Probably not a fit

Patients with irregular astigmatism, prior refractive or intraocular surgery, severe dry eye, corneal endothelial disease, uncontrolled glaucoma, macular pathology, or astigmatism outside the 0.75–2.0 D range are unlikely to benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study follows adults with age-related cataract and regular corneal astigmatism (0.75–2.0 D) who undergo femtosecond laser-assisted arcuate keratotomy at the time of cataract extraction. Investigators will collect refractive measures, corneal topography/tomography, visual acuity, and endothelial and intraocular pressure data before surgery and at multiple visits up to 5 years postoperatively. The aim is to document how much astigmatism is reduced, how stable that correction is over time, and which preoperative eye characteristics predict better or worse outcomes. Visits include early checks (1 week, 1 month), intermediate (3 and 6 months), and long-term follow-up (1, 2, and 5 years).

Why it matters

Potential benefit: If successful, the procedure could lower residual astigmatism after cataract surgery and reduce dependence on glasses for many patients.

How similar studies have gone: Previous short-term studies have shown that FSAK can reduce low-to-moderate astigmatism, but long-term (multi-year) stability and clear predictors of success remain less well documented.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

* Age: 20-80 years
* Age-related cataracts
* Regular corneal astigmatism (0.75-2.0 diopters) confirmed by Pentacam/IOLMaster 700
* Surgical Plan: Scheduled for femtosecond laser-assisted cataract surgery
* Central corneal thickness ≥500 µm
* Endothelial cell count ≥2,000 cells/mm²
* Best-corrected visual acuity (BCVA) improvable to ≥20/40

Exclusion Criteria

* Prior corneal refractive surgery (e.g., LASIK, PRK)
* Intraocular surgery (e.g., glaucoma filtering surgery)
* Irregular astigmatism (keratoconus, scarring, post-traumatic distortion)
* Active ocular inflammation or infection
* Corneal endothelial disease (e.g., Fuchs' dystrophy)
* Severe dry eye (Schirmer test ≤5 mm/5 min)
* Uncontrolled glaucoma (IOP \>21 mmHg on medication)
* Macular pathology (e.g., AMD, DME affecting visual potential)
* Amblyopia
* Autoimmune diseases affecting cornea (e.g., rheumatoid arthritis, Sjögren syndrome)
* Diabetes mellitus with retinopathy
* Pregnancy/Lactation
* Inability to complete 5-year follow-up

Where it's running

  • Eye and Ear, Nose, and Throat Hospital of Fudan University
    Shanghai, Shanghai Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.